Author: Tarek Nafee, M.D.

ACC 2018, Conferences

ACC 2018 Japanese Wrap-Up

by Tarek Nafee, M.D. March 11, 2018 0

Read more.

ACC 2018, Conferences

ACC 2018 Italian Wrap Up

by Tarek Nafee, M.D. March 11, 2018 0

Read more.

ACC 2018, Acute Coronary Syndrome, Conferences

MANAGE Trial: Dabigatran in Patients With MI After Non-Cardiac Surgery

by Tarek Nafee, M.D. March 11, 2018 0

Read more.

ACC 2018, Acute Coronary Syndrome, Conferences

ODYSSEY Outcomes: Alirocumab Reduces MACE, Non-fatal MI, Ischemic Stroke, and All-Cause Mortality in ACS Patients

by Tarek Nafee, M.D. March 11, 2018 0

Read more.

ACC 2018, Acute Coronary Syndrome, Conferences

VEST trial: Prevention of Early Sudden Death Post-MI

by Tarek Nafee, M.D. March 11, 2018 0

Read more.

ACC 2018, Acute Coronary Syndrome, Conferences

SWAP 4: Pharmacodynamic Effects of Switching from Ticagrelor to Clopidogrel in Patients with Coronary Artery Disease

by Tarek Nafee, M.D. March 11, 2018 0

Read more.

ACC 2018, Conferences

ACC 2018 Daily Wrap-Up – March 10, 2018

by Tarek Nafee, M.D. March 11, 2018 0

Read more.

ACC 2018, Acute Coronary Syndrome, Conferences, News

ODYSSEY Demonstrates a Mortality Benefit in ACS Patients

by Tarek Nafee, M.D. March 10, 2018 0

Results of the much anticipated ODYSSEY Outcomes trial were presented today by Professor Phillipe Gabriel Steg, who is the chief of cardiology at Bichat-Claude Bernard... Read more.

Cardiovascular Imaging

Incorporating Non-Invasive Fractional Flow Reserve into Clinical Practice

by Tarek Nafee, M.D. March 4, 2018 0

Read more.

Acute Coronary Syndrome

Anticipating ODYSSEY Outcomes

by Tarek Nafee, M.D. February 22, 2018 0

Read more.